ADHD, learning difficulties and sleep disturbances associated with KCNJ11-related neonatal diabetes

Karen A Landmeier1, Monica Lanning2, David Carmody2

  • 1Section Department of Developmental and Behavioral Pediatrics, The University of Chicago, Chicago, Illinois.

Pediatric Diabetes
|August 25, 2016
PubMed

Insights

Mutations in KCNJ11 cause neonatal diabetes mellitus (NDM) and are linked to increased risks of ADHD, learning delays, and sleep issues in affected children. Early support may improve neurodevelopmental outcomes.

Area of Science:

  • Endocrinology
  • Genetics
  • Neurodevelopmental Disorders

Background:

  • Mutations in KCNJ11 are the primary genetic cause of permanent neonatal diabetes mellitus (NDM).
  • While overt neurological dysfunction is observed in some NDM patients, milder neurodevelopmental concerns remain less understood.
  • Assessing parental concerns regarding learning, behavior, ADHD, social skills, and sleep is crucial for understanding the full impact of KCNJ11 mutations.

Purpose of the Study:

  • To determine the prevalence of parental concerns about learning, behavior, ADHD, social competency, and sleep in children with KCNJ11-related NDM.
  • To compare these concerns in affected children with those of unaffected sibling controls.
  • To identify potential neurodevelopmental consequences associated with KCNJ11 mutations.

Main Methods:

  • Surveys were administered to guardians of subjects in the University of Chicago Monogenic Diabetes Registry.
  • The survey assessed learning, behavior, ADHD, and sleep patterns.
  • Data from 30 subjects with KCNJ11-related NDM and 25 unaffected sibling controls were analyzed using nonparametric Fisher's exact test.

Main Results:

  • 43% of individuals with KCNJ11-related NDM had ADHD diagnoses or treatment, compared to 8% of controls (P < 0.05).
  • Significant differences were observed in behavior difficulties, social awareness, academic achievement, and the need for Individualized Education Plans (IEPs) in affected individuals.
  • Individuals with KCNJ11 mutations exhibited significantly higher rates of sleep difficulties (P < 0.01).

Conclusions:

  • Parent-reported data indicate an increased risk for learning delays, social-emotional and behavioral issues, ADHD, and sleep difficulties in patients with KCNJ11-related NDM.
  • Early identification and integrated medical and developmental support are recommended to enhance neurodevelopmental outcomes.
  • Further research with detailed neuropsychological testing is needed to fully elucidate the neurodevelopmental consequences of KATP channel mutations.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.1K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
986
Learning Disabilities01:25

Learning Disabilities

Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
718
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K
Narcolepsy01:07

Narcolepsy

Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
710